Investing.com - CryoCell International (NYSE: CCEL) reported second quarter EPS of $0.0800, $0.03 better than the analyst estimate of $0.0500. Revenue for the quarter came in at $8M versus the consensus estimate of $8M.
CryoCell International's stock price closed at $7.12. It is down -3.3900% in the last 3 months and up 7.3900% in the last 12 months.
CryoCell International saw 1 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See CryoCell International's stock price’s past reactions to earnings here.
According to InvestingPro, CryoCell International's Financial Health score is "fair performance".
Check out CryoCell International's recent earnings performance, and CryoCell International's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar